Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AZTAthis companyAzenta, Inc.	$40.14	-23.54×	0.76×	2.21×	21.18×	-69.9%	45.5%	-1.9%	-9.4%	-3.2%	2.1%	2.9%	0.06×	-3.12×	0×	2.98×	0.0%	4	3.8	2	C+
BIOBio-Rad Laboratories, Inc.	$390.14	10.87×	1.11×	3.2×	7.65×	-146.4%	52.0%	10.5%	29.4%	10.2%	2.0%	4.5%	0.21×	0.83×	5.52×	5.62×	0.0%	7	3.65	3	B
BRKRBruker Corporation	$65.82	-314.07×	2.91×	2.08×	29.4×	-38.9%	45.9%	6.9%	-0.3%	-0.4%	-1.9%	0.2%	0.83×	5.76×	3.91×	1.73×	0.3%	5	2.75	1	C-
DHRDanaher Corporation	$232.40	45.15×	3.08×	6.59×	25.3×	-14.1%	60.9%	20.9%	14.7%	6.9%	5.7%	3.2%	0.35×	1.99×	19.38×	1.87×	0.5%	7	3.74	3	B
HBIOHarvard Bioscience, Inc.	$9.07	-0.52×	2.16×	0.34×	-1.4×	-319.6%	53.0%	-0.7%	-65.5%	-412.8%	-1.0%	18.9%	3.22×	-0.77×	-0.13×	2.2×	0.0%	5	-2.53	1	D+
MLABMesa Laboratories, Inc.	$129.80	72.48×	2.62×	1.96×	17.84×	-93.2%	63.5%	7.4%	2.7%	3.6%	2.8%	8.1%	0.91×	4.02×	1.73×	1.72×	0.7%	7	2.05	2	B-
Peer median	—	10.87×	2.62×	2.08×	17.84×	-93.2%	53.0%	7.4%	2.7%	3.6%	2.0%	4.5%	0.83×	1.99×	3.91×	1.87×	0.3%	7	2.75	2	—